For decades, lung disease has been the most visible and life-threatening part of cystic fibrosis. People might picture ...

If too much phlegm is giving you unpleasant symptoms, here are the mucus-reducing foods that may help and the mucus-causing ...

Today is World Bronchiectasis Day, an observance to raise awareness about a lesser-known chronic lung disease that affects ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental ...

SC Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that deactivate mechano-sensitive ion channels (MSCs) to treat respiratory and cardiovascular disease, today reports ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Research at UVA is working to find new treatment opportunities for a lung disease growing in prominence around the world.

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

Sometimes physicians encounter symptoms that remain unexplained despite extensive testing. When no clear medical explanation is found and symptoms persist, patients often develop anxiety and/or ...

A first-of-its-kind drug has provided a "functional cure" in about 20% of patients with chronic hepatitis B infections, providing a possible lifeline for sufferers on Long Island, which has the ...

Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping all treatment. Reading time 3 minutes An experimental medication called ...

LONDON, May 28 (Reuters) - GSK (GSK.L), opens new tab said its ‌experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, raising hopes ...